Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

VIBRANT: VIB4920 for Active Lupus Nephritis

ClinicalTrials.gov ID: NCT05201469

Public ClinicalTrials.gov record NCT05201469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis (ITN091AI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).

Study identification

NCT ID
NCT05201469
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Enrollment
74 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 15, 2022
Primary completion
Jul 31, 2026
Completion
Feb 28, 2027
Last update posted
Dec 18, 2025

2022 – 2027

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology La Jolla California 92093 Recruiting
UCLA Medical Center: Division of Rheumatology Los Angeles California 90095 Recruiting
of California, Irvine School of Medicine Division of Rheumatology Orange California 92868 Recruiting
University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center San Francisco California 94143 Recruiting
University of Colorado School of Medicine: Division of Rheumatology Aurora Colorado 80045 Recruiting
Yale University School of Medicine: Section of Rheumatology New Haven Connecticut 06519 Recruiting
University of Miami Miller School of Medicine: Nephrology & Hypertension Division Miami Florida 33136 Recruiting
Emory University School of Medicine: Division of Rheumatology Atlanta Georgia 30307 Recruiting
University of Chicago, Department of Medicine: Rheumatology Chicago Illinois 60637 Recruiting
University of Michigan Ann Arbor Michigan 48109 Recruiting
Washington University School of Medicine in St. Louis: Division of Nephrology St Louis Missouri 63110 Recruiting
Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases Manhasset New York 11030 Recruiting
Hospital for Special Surgery, New York: Division of Rheumatology New York New York 10021 Not yet recruiting
Columbia University Medical Center: Department of Medicine, Division of Rheumatology New York New York 10032 Recruiting
Penn State Health Milton S. Hershey Medical Center: Division of Rheumatology Hershey Pennsylvania 17033 Recruiting
Temple University, Lewis Katz School of Medicine, Department of Medicine: Nephrology Philadelphia Pennsylvania 19140 Recruiting
University of South Carolina Charleston South Carolina 29425 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05201469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05201469 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →